ADDPLAN Enquiries


Leading the way in adaptive trial design and execution

ICON is the only CRO to offer a validated design, simulation and analysis software platform for adaptive clinical trials. ADDPLAN® is currently licensed by regulatory agencies, including the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA) and Japan’s Pharmaceuticals and Medical Devices Agency (PMDA). ADDPLAN® is also used by leading pharmaceutical and medical device companies and numerous academic researchers. 

Complete the form to speak to a member of the team regarding ADDPLAN®